AdvertiseDonate
Wednesday, November 18, 2026Local news for Dallas County, Texas.
Dallas County Herald · 3838 Oak Lawn Avenue, Suite 1000, Dallas, TX 75219
Tech · San Antonio

Primate Research: $200,000 Grant Aims to Map Molecular Drivers of Alzheimer's

Scientists at Texas Biomed and UT Health San Antonio will analyze aging baboon brains to identify early biological changes that precede clinical symptoms of the disease.

By Nathan Brooks ·

Illustration for: Primate Research: $200,000 Grant Aims to Map Molecular Drivers of Alzheimer's
Illustration generated for this article, not a news photograph.

Twenty million Americans do not yet know they have Alzheimer's, but for researchers in San Antonio, the critical window for intervention opens long before diagnosis. A new study funded by $200,000 from the San Antonio Medical Foundation seeks to identify the molecular events in the brain that precede the visible signs of the disease.

The project involves scientists from the Texas Biomedical Research Institute and UT Health San Antonio. They will examine the brains of aging baboons at the Southwest National Primate Research Center. Baboons are primates with brain structures that closely resemble human anatomy, making them a suitable model for studying neurodegeneration.

The study addresses a gap in current medical knowledge. While doctors understand risk factors such as genetics, high blood pressure, and head trauma, the internal mechanisms driving Alzheimer's remain unclear. Beta-amyloid plaques and tau protein tangles are known markers, but their exact role in causing the disease is still debated.

Eric Vallender, associate director for research at the Texas Biomed primate center, noted that much more occurs in the brain than just the accumulation of these two proteins. The team will use spatial proteomics, a technique that maps proteins within tissue, to analyze small brain samples. This method allows researchers to observe molecular activity in specific locations within the brain.

Cognitive tests and blood biomarkers will accompany the tissue analysis. This data will help determine how current diagnostic metrics correlate with actual brain changes. Vallender is specifically investigating the blood-brain barrier, a protective lining that can deteriorate with age and lead to inflammation.

Kimberley Phillips, a psychology professor at Trinity University and researcher at Texas Biomed, is focusing on glial cells. These are the brain's support cells, and their role in neurodegeneration is not fully understood. Phillips stated that the goal is earlier detection, which could allow for interventions that delay or alter the disease's progression.

Currently, Alzheimer's testing is generally reserved for patients who are already showing symptoms. The disease process, however, begins years before those symptoms appear. Two drugs, Leqembi and Kisunla, were approved by the U.S. Food and Drug Administration in 2023 and 2024. Both target beta-amyloid plaque to slow progression in early stages, but neither reverses the condition.

Adam Salmon, associate director of the Sam and Ann Barshop Institute for Longevity and Aging Studies at UT San Antonio, is studying mitochondria. These organelles maintain cellular energy, and their failure is linked to cognitive decline. Salmon believes that preserving mitochondrial function could preserve cognitive function. The team will use the initial funding for a one-year pilot study before seeking additional resources.

More Tech · Report a business · Got a Story?

Get Dallas County Herald in your inboxLocal news for Dallas County, Texas. Free, a few times a week, unsubscribe any time.

Get Dallas County Herald in your inboxLocal news for Dallas County, Texas. Free, a few times a week, unsubscribe any time.